Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
Abstract
Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a pharmaceutically acceptable carrier is described. According to another embodiment, the subject disclosure features method of treating a depressive disorder or an anxiety disorder in a subject in need of such treatment. The method may comprise administering to the subject a therapeutically effective amount of a composition comprising PG-20N.
Subject
A61K 38/08A61K 9/0019
A61K 9/0053
A61K 38/10
A61K 38/12
A61K 38/177
A61K 47/24
C07D 473/00
C07D 7/06
C07D 7/08
C07D 14/68
C07D 14/685
C07D 14/723
G01N 2333/72
G01N 2500/10
A61K 31/54
Collections
Citation
Hruby, Victor J.; Cai, Minying; Morgan, Caurnel (2020). Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /188149.